The Impact of Hormonal Contraceptives on the Incidence and Progression of Cardiovascular Diseases in Women: A Systematic Review
- PMID: 39184751
- PMCID: PMC11344578
- DOI: 10.7759/cureus.65366
The Impact of Hormonal Contraceptives on the Incidence and Progression of Cardiovascular Diseases in Women: A Systematic Review
Abstract
This systematic review examines the impact of hormonal contraceptives on the incidence and progression of cardiovascular diseases in women. We analyzed 14 high-quality studies published between 1998 and 2018, including meta-analyses, cohort studies, case-control studies, and systematic reviews. The aim was to synthesize the current understanding of the relationship between various hormonal contraceptives and cardiovascular risks, focusing on outcomes such as venous thromboembolism, ischemic stroke, and myocardial infarction. The 14 selected studies represent a comprehensive and diverse body of evidence, allowing for a nuanced analysis of the topic. Our findings indicate that combined oral contraceptives are associated with an increased risk of cardiovascular events, with the magnitude of risk varying based on estrogen dose, progestogen type, and individual risk factors. The review of these studies highlights the importance of personalized risk assessment in contraceptive counseling and prescribing practices. By synthesizing data from these key studies, we provide a consolidated view of the current state of knowledge regarding hormonal contraceptives and cardiovascular health, offering valuable insights for both clinicians and researchers in the field.
Keywords: cardiovascular diseases; hormonal contraceptives; ischemic stroke; myocardial infarction; venous thromboembolism.
Copyright © 2024, Asubiaro et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- History of oral contraceptive drugs and their use worldwide. Christin-Maitre S. Best Pract Res Clin Endocrinol Metab. 2013;27:3–12. - PubMed
-
- Estrogens, progestogens and thrombosis. Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. J Thromb Haemost. 2003;1:1371–1380. - PubMed
-
- Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. https://doi.org/10.1136/bmj.f5298 BMJ. 2013;347:0. - PMC - PubMed
-
- Metabolic effects of contraceptive steroids. Sitruk-Ware R, Nath A. Rev Endocr Metab Disord. 2011;12:63–75. - PubMed
-
- Thrombotic stroke and myocardial infarction with hormonal contraception. Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. N Engl J Med. 2012;366:2257–2266. - PubMed
Publication types
LinkOut - more resources
Full Text Sources